Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation
Authors:
- Angelo A V De PaolaAPAngelo A V De Paola
- Edilberto FigueiredoEFEdilberto Figueiredo
- Ricardo SessoRSRicardo Sesso
- Henrique H VelosoHVHenrique H Veloso
- Luiz Olympio T NascimentoLNLuiz Olympio T Nascimento
- SOCES InvestigatorsSISOCES Investigators
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 88 (2-3) , 157-166
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillationThe American Journal of Cardiology, 1999
- Management of Patients With Atrial FibrillationCirculation, 1996
- Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic TreatmentMayo Clinic Proceedings, 1996
- Benefits and Risks of Antiarrhythmic Drug Therapy after DC Electrical Cardioversion of Atrial Fibrillation or FlutterEuropean Heart Journal, 1994
- A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythmInternational Journal of Cardiology, 1994
- A Clinician's Guide to Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1990
- Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1986
- Maintenance of sinus rhythm after DC reversion of atrial fibrillation: A double-blind controlled trial of long-acting quinidine bisulphateHeart, 1970
- Electrical reversion of cardiac arrhythmias.Heart, 1967
- Direct current shock therapy of cardiac arrhythmias.Heart, 1966